FRES
Fresh2 Group Ltd
NASDAQ: FRES · HEALTHCARE · DIAGNOSTICS & RESEARCH
$0.85
+0.00% today
Updated 2026-04-30
Market cap
$2.97M
P/E ratio
—
P/S ratio
0.12x
EPS (TTM)
$-72.68
Dividend yield
—
52W range
$0 – $0
Volume
0.3M
Fresh2 Group Ltd (FRES) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Revenue | $10.82M | $19.39M | $17.75M | $12.04M |
| Revenue growth (YoY) | — | +79.3% | -8.4% | -32.2% |
| Cost of revenue | $6.03M | $7.21M | $5.66M | $3.71M |
| Gross profit | $4.79M | $12.18M | $12.10M | $8.34M |
| Gross margin | 44.2% | 62.8% | 68.1% | 69.2% |
| R&D | $9.81M | $10.94M | $15.99M | $9.53M |
| SG&A | $476.10M | $487.82M | $513.57M | $70.79M |
| Operating income | $-89.21M | $-88.04M | $-104.67M | $-104.81M |
| Operating margin | -824.9% | -454.1% | -589.6% | -870.2% |
| EBITDA | $-665.46M | $-498.64M | $-719.98M | $-99.86M |
| EBITDA margin | -6152.7% | -2571.7% | -4055.5% | -829.1% |
| EBIT | $-668.08M | $-501.54M | $-722.70M | $-105.36M |
| Interest expense | $17.98M | $7.46M | $27.10M | $373000.00 |
| Income tax | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-100.79M | $-76.08M | $-117.16M | $-101.89M |
| Net income growth (YoY) | — | +24.5% | -54.0% | +13.0% |
| Profit margin | -931.9% | -392.4% | -659.9% | -846.0% |